EPALINGES, Switzerland, Oct. 27, 2025 /PRNewswire/ — Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics…
Onward Therapeutics Exercises Exclusive Option and Signs Worldwide License Agreement with Institut du Cancer de Montpellier for Novel Onco-Metabolism Program
